Removal of access to alemtuzumab for patients with aggressive multiple sclerosis

被引:1
|
作者
Thompson, Alan J. [1 ]
Giovannoni, Gavin [2 ]
机构
[1] UCL, UCL Inst Neurol, London WC1N 3BG, England
[2] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England
来源
关键词
CONTROLLED PHASE-3 TRIAL;
D O I
10.1136/bmj.f275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Observational study on real-life experience with alemtuzumab in naive patients with aggressive Multiple Sclerosis
    Moiola, L.
    Di Cristinzi, M.
    Zanetta, C.
    Rinaldi, F.
    Brambilla, L.
    Annovazzi, P.
    Frau, J.
    Malucchi, S.
    Lanzillo, R.
    Lus, G.
    Cavalla, P.
    Gallo, A.
    Barcella, V.
    Bucello, S.
    Marfia, G.
    Totaro, R.
    Cerqua, R.
    Baldi, E.
    Chiveri, L.
    Tortorella, C.
    Tonietti, S.
    Lapucci, C.
    Santuccio, G.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 204 - 204
  • [2] Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab
    Ines Gaitan, Maria
    Celica Ysrraelit, Maria
    Correale, Jorge
    JAMA NEUROLOGY, 2017, 74 (09) : 1143 - 1144
  • [3] Alemtuzumab for multiple sclerosis
    不详
    LANCET, 2012, 380 (9856): : 1792 - 1792
  • [4] Alemtuzumab for multiple sclerosis
    Riera, Rachel
    Porfirio, Gustavo J. M.
    Torloni, Maria R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [5] Alemtuzumab for Multiple Sclerosis
    Mark D. Willis
    Neil P. Robertson
    Current Neurology and Neuroscience Reports, 2016, 16
  • [6] Alemtuzumab for multiple sclerosis
    Riera, Rachel
    Torloni, Maria Regina
    Martimbianco, Ana Luiza C.
    Pacheco, Rafael L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
  • [7] Alemtuzumab in Multiple Sclerosis
    Azzopardi, Laura
    Coles, Alasdair
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 79 - 82
  • [8] Alemtuzumab for Multiple Sclerosis
    Willis, Mark D.
    Robertson, Neil P.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (09)
  • [9] Alemtuzumab as rescue therapy in a cohort of 15 aggressive multiple sclerosis patients previously treated by mitoxantrone: an observational study
    Le Page, E.
    Deburghgraeve, V.
    Edan, G.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 272 - 273
  • [10] Alemtuzumab as rescue therapy in a cohort of 15 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study
    Le Page, E.
    Deburghgraeve, V.
    Cardiet, I.
    Lester, M. A.
    Edan, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 191 - 191